A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence

NCT03656120 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Opioid Dependence

Interventions

DRUG: 0.2mg group
DRUG: 0.5mg group
DRUG: placebo control group

Sponsor

Wei Hao

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]